** Shares of medical device maker Hologic fall 4.7% to $79.77, the lowest since August
** HOLX said late on Monday it expects 2025 revenue in range of $4.15 bln to $4.20 bln, below analysts' average estimate of $4.21 bln - LSEG data
** Co said its full-year forecast included an expected impact from ongoing temporary halt in shipping of its bone density scanning machine, Horizon DXA systems
** Co reported Q4 adj. profit of $1.01/shr, in line with analysts' estimates
** Stock up 11.6% YTD
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments